ARTICLE | Clinical News
Microplasmin: Additional Phase II data
February 15, 2010 8:00 AM UTC
Additional data from the double-blind Phase II MIVI III trial in 125 patients showed that single intravitreous injections of 25, 75 or 125 µg microplasmin administered 7 days before a scheduled vitrec...